Clinical Trials
- Diabetes
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
- Ages10 years - 17 years
- GenderBoth
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention Study
- Ages1 year - 45 years
- GenderBoth
- Children's Health, Diabetes
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D) (CITY)
- Ages14 years - 24 years
- GenderBoth
- Children's Health, Diabetes
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
- Ages7 years - 75 years
- GenderBoth
- Diabetes
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer) A Proof-of-Concept Study
- Ages7 years - 17 years
- GenderBoth
- Diabetes
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
- Ages12 years - 24 years
- GenderBoth
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Children's Health, Diabetes, Heart/Cardiovascular, Endocrine System, Genetics, Obesity & Weight Management
Prevalence of Carbohydrate Intolerance in Lean and Obese Children
- Ages8 years - 18 years
- GenderBoth
- Diabetes
FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients
- Ages4 years - 17 years
- GenderBoth
- Blood Disorders, COVID-19 Inpatient, COVID-19 Outpatient
Mechanisms for restoration of hypoglycemia awareness